These results suggested that, at least at the mRNA expression level, the bioactive effects of platelets are largely mediated by TGF-β secreted from activated platelets, as suggested by experiments of other tumor cells treated with murine platelets [15, 17]. The gene discussed is TGFB1; the disease is neoplasm.